Non-Invasive Prenatal Testing Market Status, Growth Opportunity, Key Manufacturers Profile, and Demand Forecast to 2020
The global
NIPT market is growing, due to increasing healthcare expenditure. The average
maternal age is increasing in high income countries, due to changing pattern of
employment, education and marriage, and increasing cost of raising a child. The
increase in average maternal age is resulting in the growth of the global NIPT
market. Chromosome syndromes are caused, due to chromosomal abnormalities in
the humans, which is leading to genetic cause of miscarriage and congenital
birth defects. According to the World Health Organization (WHO), each year
approximately 3,000 to 5,000 children are born with chromosome disorder. Thus,
with the increase in chromosome syndrome cases, the need for early and advance
prenatal screening is increasing, which is resulting in increased demand for
NIPT.
The testing
and screening for fetal abnormalities has changed the women’s experience of
pregnancy. Prenatal tests are medical tests performed during the pregnancy, in
order to determine the development of fetus. However, various committees across
the globe believe that the implementation of NIPT and consequent increase in
prenatal testing would increase the incidence of abortions.
Download Report
Sample at:
However,
certain restraints such as strict regulatory requirements and ethical hurdles
are hindering the growth of the market. The increasing awareness about NIPT and
improving healthcare facilities in developing countries, such as China and
India, are laying significant growth opportunities for NIPT market. The
Asia-Pacific market is expected to witness the fastest growth (CAGR 18.1%)
globally during the period 2015 – 2020.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=non-invasive-prenatal-testing-market
The key
companies operating in the global NIPT market include Sequenom Inc., BGI, LifeCodexx AG, Quest
Diagnostics Incorporated, Hoffmann-La Roche Ltd., Illumina Inc., Berry Genomics
Co. Ltd., Laboratory Corporation of America Holdings, and Natera Inc.
Comments
Post a Comment